O	0	13	Effectiveness
O	14	16	of
B-intervention	17	22	nurse
I-intervention	22	23	-
I-intervention	23	26	led
I-intervention	27	32	group
I-intervention	33	36	CBT
O	37	40	for
B-condition	41	44	hot
I-condition	45	52	flushes
I-condition	53	56	and
I-condition	57	62	night
I-condition	63	69	sweats
O	70	72	in
O	73	78	women
O	79	83	with
O	84	90	breast
O	91	97	cancer
O	97	98	:
O	99	106	Results
O	107	109	of
O	110	113	the
O	114	120	MENOS4
O	121	131	randomised
O	132	142	controlled
O	143	148	trial
O	148	149	.

O	150	161	Troublesome
O	162	165	hot
O	166	173	flushes
O	174	177	and
O	178	183	night
O	184	190	sweats
O	191	192	(
O	192	196	HFNS
O	196	197	)
O	198	201	are
O	202	213	experienced
O	214	216	by
O	217	221	many
O	222	227	women
O	228	233	after
O	234	243	treatment
O	244	247	for
O	248	254	breast
O	255	261	cancer
O	261	262	,
O	263	272	impacting
O	273	286	significantly
O	287	289	on
O	290	295	sleep
O	296	299	and
O	300	307	quality
O	308	310	of
O	311	315	life
O	315	316	.

O	317	326	Cognitive
O	327	338	behavioural
O	339	346	therapy
O	347	348	(
O	348	351	CBT
O	351	352	)
O	353	355	is
O	356	361	known
O	362	364	to
O	365	367	be
O	368	377	effective
O	378	381	for
O	382	385	the
O	386	397	alleviation
O	398	400	of
O	401	405	HFNS
O	405	406	.

O	407	414	However
O	414	415	,
O	416	418	it
O	419	421	is
O	422	425	not
O	426	431	known
O	432	434	if
O	435	437	it
O	438	441	can
O	442	453	effectively
O	454	456	be
O	457	466	delivered
O	467	469	by
O	470	480	specialist
O	481	487	nurses
O	487	488	.

O	489	491	We
O	492	504	investigated
O	505	512	whether
O	513	518	group
O	519	522	CBT
O	522	523	,
O	524	533	delivered
O	534	536	by
O	537	543	breast
O	544	548	care
O	549	555	nurses
O	556	557	(
O	557	561	BCNs
O	561	562	)
O	562	563	,
O	564	567	can
O	568	574	reduce
O	575	578	the
O	579	585	impact
O	586	588	of
O	589	593	HFNS
O	593	594	.

O	595	597	We
O	598	607	recruited
B-eligibility	608	613	women
I-eligibility	614	618	with
I-eligibility	619	626	primary
I-eligibility	627	633	breast
I-eligibility	634	640	cancer
I-eligibility	641	650	following
I-eligibility	651	658	primary
I-eligibility	659	668	treatment
I-eligibility	669	673	with
I-eligibility	674	679	seven
I-eligibility	680	682	or
I-eligibility	683	687	more
I-eligibility	688	692	HFNS
I-eligibility	692	693	/
I-eligibility	693	697	week
O	698	699	(
O	699	708	including
O	709	710	4
O	710	711	/
O	711	713	10
O	714	716	or
O	717	722	above
O	723	725	on
O	726	729	the
O	730	734	HFNS
O	735	742	problem
O	743	749	rating
O	750	755	scale
O	755	756	)
O	756	757	,
O	758	762	from
O	763	766	six
B-location	767	769	UK
O	770	779	hospitals
O	780	782	to
O	783	785	an
O	786	790	open
O	790	791	,
O	792	802	randomised
O	802	803	,
O	804	809	phase
O	810	811	3
O	812	825	effectiveness
O	826	831	trial
O	831	832	.

O	833	845	Participants
O	846	850	were
O	851	861	randomised
O	862	864	to
O	865	870	Group
O	871	874	CBT
O	875	877	or
B-control	878	883	usual
I-control	884	888	care
I-control	889	890	(
I-control	890	892	UC
I-control	892	893	)
O	893	894	.

O	895	898	The
O	899	906	primary
O	907	915	endpoint
O	916	919	was
B-outcome-Measure	920	924	HFNS
I-outcome-Measure	925	932	problem
I-outcome-Measure	933	939	rating
I-outcome-Measure	940	942	at
I-outcome-Measure	943	945	26
I-outcome-Measure	946	951	weeks
I-outcome-Measure	952	957	after
I-outcome-Measure	958	971	randomisation
O	971	972	.

O	973	982	Secondary
O	983	991	outcomes
O	992	1000	included
B-outcome-Measure	1001	1006	sleep
O	1006	1007	,
B-outcome-Measure	1008	1018	depression
O	1018	1019	,
B-outcome-Measure	1020	1027	anxiety
O	1028	1031	and
B-outcome-Measure	1032	1039	quality
I-outcome-Measure	1040	1042	of
I-outcome-Measure	1043	1047	life
O	1047	1048	.

O	1049	1056	Between
O	1057	1061	2017
O	1062	1065	and
O	1066	1070	2018
O	1070	1071	,
B-total-participants	1072	1075	130
O	1076	1088	participants
O	1089	1093	were
O	1094	1103	recruited
O	1104	1105	(
O	1105	1108	CBT
O	1108	1109	:
B-intervention-participants	1109	1111	63
O	1111	1112	,
O	1113	1120	control
O	1120	1121	:
B-control-participants	1121	1123	67
O	1123	1124	)
O	1124	1125	.

O	1126	1128	We
O	1129	1134	found
O	1135	1136	a
O	1137	1139	46
O	1139	1140	%
O	1141	1142	(
O	1142	1143	6
O	1143	1144	.
O	1144	1145	9
O	1145	1146	-
O	1146	1147	3
O	1147	1148	.
O	1148	1149	7
O	1149	1150	)
B-outcome	1151	1160	reduction
I-outcome	1161	1163	in
I-outcome	1164	1167	the
I-outcome	1168	1172	mean
I-outcome	1173	1177	HFNS
O	1178	1185	problem
O	1186	1192	rating
O	1193	1198	score
O	1199	1203	from
O	1204	1217	randomisation
O	1218	1220	to
O	1221	1223	26
O	1224	1229	weeks
O	1230	1232	in
O	1233	1236	the
O	1237	1240	CBT
O	1241	1244	arm
O	1245	1248	and
O	1249	1250	a
O	1251	1253	15
O	1253	1254	%
O	1255	1256	(
O	1256	1257	6
O	1257	1258	.
O	1258	1259	5
O	1259	1260	-
O	1260	1261	5
O	1261	1262	.
O	1262	1263	5
O	1263	1264	)
O	1265	1274	reduction
O	1275	1277	in
O	1278	1281	the
O	1282	1284	UC
O	1285	1288	arm
O	1289	1290	(
O	1290	1298	adjusted
O	1299	1303	mean
O	1304	1314	difference
O	1315	1316	-
O	1316	1317	1
O	1317	1318	.
O	1318	1320	96
O	1320	1321	,
O	1322	1324	CI
O	1325	1326	-
O	1326	1327	3
O	1327	1328	.
O	1328	1330	68
O	1331	1333	to
O	1334	1335	-
O	1335	1336	0
O	1336	1337	.
O	1337	1339	23
O	1339	1340	,
O	1341	1342	P
O	1343	1344	=
O	1345	1346	.
O	1346	1349	039
O	1349	1350	)
O	1350	1351	.

O	1352	1361	Secondary
O	1362	1370	outcomes
O	1370	1371	,
O	1372	1381	including
B-outcome	1382	1391	frequency
I-outcome	1392	1394	of
I-outcome	1395	1399	HFNS
I-outcome	1399	1400	,
I-outcome	1401	1406	sleep
I-outcome	1406	1407	,
I-outcome	1408	1415	anxiety
I-outcome	1416	1419	and
I-outcome	1420	1430	depression
O	1431	1434	all
O	1435	1443	improved
O	1444	1457	significantly
O	1457	1458	.

O	1459	1462	Our
O	1463	1470	results
O	1471	1478	suggest
O	1479	1483	that
O	1484	1494	specialist
O	1495	1501	nurses
O	1502	1505	can
O	1506	1508	be
O	1509	1516	trained
O	1517	1519	to
O	1520	1527	deliver
O	1528	1531	CBT
O	1532	1543	effectively
O	1544	1546	to
O	1547	1556	alleviate
O	1557	1568	troublesome
O	1569	1579	menopausal
O	1580	1583	hot
O	1584	1591	flushes
O	1592	1594	in
O	1595	1600	women
O	1601	1610	following
O	1611	1617	breast
O	1618	1624	cancer
O	1625	1627	in
O	1628	1631	the
O	1632	1635	NHS
O	1636	1643	setting
O	1643	1644	.
